These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20554567)

  • 1. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.
    Hsu DI; Nguyen M; Nguyen L; Law A; Wong-Beringer A
    J Antimicrob Chemother; 2010 Aug; 65(8):1765-70. PubMed ID: 20554567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin for invasive candidiasis at a tertiary care medical center.
    Zaas AK; Dodds Ashley ES; Alexander BD; Johnson MD; Perfect JR
    Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
    Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
    J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
    Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin for the treatment of less common forms of invasive candidiasis.
    Cornely OA; Lasso M; Betts R; Klimko N; Vazquez J; Dobb G; Velez J; Williams-Diaz A; Lipka J; Taylor A; Sable C; Kartsonis N
    J Antimicrob Chemother; 2007 Aug; 60(2):363-9. PubMed ID: 17526917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study.
    Sipsas NV; Lewis RE; Raad II; Kontoyiannis DP
    Int J Antimicrob Agents; 2009 Jul; 34(1):95-8. PubMed ID: 19251404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efungumab and caspofungin: pre-clinical data supporting synergy.
    Hodgetts S; Nooney L; Al-Akeel R; Curry A; Awad S; Matthews R; Burnie J
    J Antimicrob Chemother; 2008 May; 61(5):1132-9. PubMed ID: 18299636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
    Kullberg BJ; Vasquez J; Mootsikapun P; Nucci M; Paiva JA; Garbino J; Yan JL; Aram J; Capparella MR; Conte U; Schlamm H; Swanson R; Herbrecht R
    J Antimicrob Chemother; 2017 Aug; 72(8):2368-2377. PubMed ID: 28459966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
    Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
    Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
    J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
    Berényi R; Kovács R; Domán M; Gesztelyi R; Kardos G; Juhász B; Perlin D; Majoros L
    New Microbiol; 2014 Jul; 37(3):355-62. PubMed ID: 25180850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.